|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Adams BD, Parsons C, Walker L, Zhang WC
and Slack FJ: Targeting noncoding RNAs in disease. J Clin Invest.
127:761–771. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lekka E and Hall J: Noncoding RNAs in
disease. FEBS Lett. 592:2884–2900. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lorenzi L, Avila Cobos F, Decock A,
Everaert C, Helsmoortel H, Lefever S, Verboom K, Volders PJ,
Speleman F, Vandesompele J and Mestdagh P: Long noncoding RNA
expression profiling in cancer: Challenges and opportunities. Genes
Chromosomes Cancer. 58:191–199. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garzon R, Marcucci G and Croce CM:
Targeting microRNAs in cancer: Rationale, strategies and
challenges. Nat Rev Drug Discov. 9:775–789. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Corté H, Manceau G, Blons H and
Laurent-Puig P: MicroRNA and colorectal cancer. Dig Liver Dis.
44:195–200. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang L, Belaguli N and Berger DH: MicroRNA
and colorectal cancer. World J Surg. 33:638–646. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Acunzo M, Romano G, Wernicke D and Croce
CM: MicroRNA and cancer-a brief overview. Adv Biol Regul. 57:1–9.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wilusz JE and Sharp PA: Molecular biology.
A circuitous route to noncoding RNA. Science. 340:440–441. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qu S, Zhong Y, Shang R, Zhang X, Song W,
Kjems J and Li H: The emerging landscape of circular RNA in life
processes. RNA Biol. 14:992–999. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou DN, Ye CS and Deng YF: CircRNAs:
Potency of protein translation and feasibility of novel biomarkers
and therapeutic targets for head and neck cancers. Am J Transl Res.
12:1535–1552. 2020.PubMed/NCBI
|
|
12
|
Liu J, Zhang X, Yan M and Li H: Emerging
role of circular RNAs in cancer. Front Oncol. 10:6632020.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhong Z, Huang M, Lv M, He Y, Duan C,
Zhang L and Chen J: Circular RNA MYLK as a competing endogenous RNA
promotes bladder cancer progression through modulating VEGFA/VEGFR2
signaling pathway. Cancer Lett. 403:305–317. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Barrett SP and Salzman J: Circular RNAs:
Analysis, expression and potential functions. Development.
143:1838–1847. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang L, Dong X, Yan B, Yu W and Shan L:
CircAGFG1 drives metastasis and stemness in colorectal cancer by
modulating YY1/CTNNB1. Cell Death Dis. 11:5422020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng Q, Bao C, Guo W, Li S, Chen J, Chen
B, Luo Y, Lyu D, Li Y, Shi G, et al: Circular RNA profiling reveals
an abundant circHIPK3 that regulates cell growth by sponging
multiple miRNAs. Nat Commun. 7:112152016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Colaprico A, Silva TC, Olsen C, Garofano
L, Cava C, Garolini D, Sabedot TS, Malta TM, Pagnotta SM,
Castiglioni I, et al: TCGAbiolinks: An R/bioconductor package for
integrative analysis of TCGA data. Nucleic Acids Res. 44:e712016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zellweger T, Miyake H, Cooper S, Chi K,
Conklin BS, Monia BP and Gleave ME: Antitumor activity of antisense
clusterin oligonucleotides is improved in vitro and in vivo by
incorporation of 2′-O-(2-methoxy)ethyl chemistry. J Pharmacol Exp
Ther. 298:934–940. 2001.PubMed/NCBI
|
|
19
|
Zhao ZJ and Shen J: Circular RNA
participates in the carcinogenesis and the malignant behavior of
cancer. RNA Biol. 14:514–521. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gwak J, Jeong H, Lee K, Shin JY, Sim T, Na
J, Kim J and Ju BG: SFMBT2-mediated infiltration of preadipocytes
and TAMs in prostate cancer. Cancers (Basel). 12:27182020.
View Article : Google Scholar
|
|
21
|
Gwak J, Shin JY, Lee K, Hong SK, Oh S, Goh
SH, Kim WS and Ju BG: SFMBT2 (Scm-like with four mbt domains 2)
negatively regulates cell migration and invasion in prostate cancer
cells. Oncotarget. 7:48250–48264. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma T and Zhang J: Upregulation of FOXP4 in
breast cancer promotes migration and invasion through facilitating
EMT. Cancer Manag Res. 11:2783–2793. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang G and Zhang G: Upregulation of FoxP4
in HCC promotes migration and invasion through regulation of EMT.
Oncol Lett. 17:3944–3951. 2019.PubMed/NCBI
|
|
24
|
Tan GZ, Li M, Tan X, Shi ML and Mou K:
miR-491 suppresses migration and invasion via directly targeting
TPX2 in breast cancer. Eur Rev Med Pharmacol Sci. 23:9996–10004.
2019.PubMed/NCBI
|
|
25
|
Meng Y, Shang FR and Zhu YL: miR-491
functions as a tumor suppressor through Wnt3a/β-catenin signaling
in the development of glioma. Eur Rev Med Pharmacol Sci.
23:10899–10907. 2019.PubMed/NCBI
|
|
26
|
Liu Z, Lü Y, Jiang Q, Yang Y, Dang C and
Sun R: miR-491 inhibits BGC-823 cell migration via targeting HMGA2.
Int J Biol Markers. 34:364–372. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu T, Wang LN, Li W, Zuo QF, Li MM, Zou QM
and Xiao B: Downregulation of miR-491-5p promotes gastric cancer
metastasis by regulating SNAIL and FGFR4. Cancer Sci.
109:1393–1403. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu Y, Hou R, Lu Q, Zhang Y, Chen L, Zheng
Y and Hu B: miR-491-5p negatively regulates cell proliferation and
motility by targeting PDGFRA in prostate cancer. Am J Cancer Res.
7:2545–2553. 2017.PubMed/NCBI
|
|
29
|
Cheng Q, Xu X, Jiang H, Xu L and Li Q:
Knockdown of long non-coding RNA XIST suppresses nasopharyngeal
carcinoma progression by activating miR-491-5p. J Cell Biochem.
119:3936–3944. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hanisch C, Sharbati J, Kutz-Lohroff B,
Huber O, Einspanier R and Sharbati S: TFF3-dependent resistance of
human colorectal adenocarcinoma cells HT-29/B6 to apoptosis is
mediated by miR-491-5p regulation of lncRNA PRINS. Cell Death
Discov. 3:161062017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen LL: The expanding regulatory
mechanisms and cellular functions of circular RNAs. Nat Rev Mol
Cell Biol. 21:475–490. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou ZB, Huang GX, Fu Q, Han B, Lu JJ,
Chen AM and Zhu L: circRNA.33186 contributes to the pathogenesis of
osteoarthritis by sponging miR-127-5p. Mol Ther. 27:531–541. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu Z, Yu Y, Huang Z, Kong Y, Hu X, Xiao
W, Quan J and Fan X: CircRNA-5692 inhibits the progression of
hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP
expression. Cell Death Dis. 10:9002019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P
and Wu M: CircRNA: Functions and properties of a novel potential
biomarker for cancer. Mol Cancer. 16:942017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hsiao KY, Lin YC, Gupta SK, Chang N, Yen
L, Sun HS and Tsai SJ: Noncoding effects of circular RNA CCDC66
promote colon cancer growth and metastasis. Cancer Res.
77:2339–2350. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang K, Sun Y, Tao W, Fei X and Chang C:
Androgen receptor (AR) promotes clear cell renal cell carcinoma
(ccRCC) migration and invasion via altering the
circHIAT1miR-195-5p/29a-3p/29c-3p/CDC42 signals. Cancer Lett.
394:1–12. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guo X, Dai X, Liu J, Cheng A, Qin C and
Wang Z: Circular RNA circREPS2 Acts as a sponge of miR-558 to
suppress gastric cancer progression by regulating RUNX3/β-catenin
signaling. Mol Ther Nucleic Acids. 21:577–591. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhao WX, Tang YL, Wang WH and Bao MW:
Up-regulation of circ_0000353 impedes the proliferation and
metastasis of non-small cell lung cancer cells via adsorbing
miR-411-5p and increasing forkhead box O1. Cancer Biomark.
29:25–37. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lee K, Na W, Maeng JH, Wu H and Ju BG:
Regulation of DU145 prostate cancer cell growth by Scm-like with
four mbt domains 2. J Biosci. 38:105–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hussain S, Sun M, Guo Y, Mushtaq N, Zhao
Y, Yuan Y, Hussain N, Osoro E, Suleiman A, Sadiq M, et al: SFMBT2
positively regulates SOX9 and chondrocyte proliferation. Int J Mol
Med. 42:3503–3512. 2018.PubMed/NCBI
|
|
41
|
Litke JL and Jaffrey SR: Highly efficient
expression of circular RNA aptamers in cells using autocatalytic
transcripts. Nat Biotechnol. 37:667–675. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jost I, Shalamova LA, Gerresheim GK,
Niepmann M, Bindereif A and Rossbach O: Functional sequestration of
microRNA-122 from hepatitis C virus by circular RNA sponges. RNA
Biol. 15:1032–1039. 2018.PubMed/NCBI
|
|
43
|
Liu CX, Li X, Nan F, Jiang S, Gao X, Guo
SK, Xue W, Cui Y, Dong K, Ding H, et al: Structure and degradation
of circular RNAs regulate PKR activation in innate immunity. Cell.
177:865–880.e21. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chen YG, Kim MV, Chen X, Batista PJ,
Aoyama S, Wilusz JE, Iwasaki A and Chang HY: Sensing self and
foreign circular RNAs by intron identity. Mol Cell. 67:228–238.e5.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bahn JH, Zhang Q, Li F, Chan TM, Lin X,
Kim Y, Wong DT and Xiao X: The landscape of microRNA,
Piwi-interacting RNA, and circular RNA in human saliva. Clin Chem.
61:221–230. 2015. View Article : Google Scholar : PubMed/NCBI
|
